author-photo

Luis Vicioso

Victoria University, Australia

30

Papers

469

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Abstract P1-10-26: Gene expression levels of DTX3, CACNA1G, IL11, ETV4 and TSPAN7 selected by LASSO penalty regression could predict pCR after neoadjuvant chemotherapy in breast cancer tumors

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data

2019 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis

2019 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (18)
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes

2018 Modern Pathology
Show All
- Source
- Cite
- Save
Citations (7)
Prognostic significance of immunohistochemical subtyping and PAM50 intrinsic subtypes in male breast cancer (MaBC)

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P3-07-15: Prosigna® subtype correlation is a strong predictor of response to neoadjuvant chemotherapy (NAC) in early breast cancer (EBC) study

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P3-07-14: Prosigna® intrinsic subtyping predicts response to neoadjuvant combination therapy in study that includes herceptin within HER2+ (IHC) patients

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.

2015 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (7)